athenahealth, Inc. Reports Second Quarter Fiscal Year 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- Citi initiates UiPath coverage with Buy rating and $23 target
- Trump says Canada's Bombardier must build jets in US or lose market access
- European shares subdued as surging crude sharpens focus on ECB rate path
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Alibaba (BABA) PT Lowered to $165 at Bernstein SocGen Group
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
FBR Capital Cuts Price Target on Athenahealth (ATHN) Following 2Q Miss
July 22, 2016 7:13 AM EDTFBR Capital reiterated a Market Perform rating on Athenahealth (NASDAQ: ATHN), and cut the price target to $140.00 (from $145.00), following the company's 2Q earnings report. Revenue was $262 million, below the consensus of $274 million. Non-GAAP adjusted EPS was $0.34, compared with the consensus of $0.42.
Analyst Steven Halper... More
Deutsche Bank Downgrades athenahealth (ATHN) to Hold
July 22, 2016 6:58 AM EDTDeutsche Bank downgraded athenahealth (NASDAQ: ATHN) from Buy to Hold with a price target of $147.00 (from $165.00). Analyst George Hill pointed out disturbing underlying performance metrics.
"Athena reported concerning Q2 results after market close, where the revenue and earnings miss was among the... More
UPDATE: Athenahealth (ATHN) Misses Q2 EPS by 8c, COO to Step Down at Year-End
July 21, 2016 4:06 PM EDT(Updated - July 25, 2016 10:31 AM EDT)
(Update corrects headline to say COO to step down, not CEO)
Athenahealth (NASDAQ: ATHN) reported Q2 EPS of $0.34, $0.08 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $261.9 million versus the consensus estimate of $274.07... More
